Yatırımcı.AI

GUBRF vs MEDTR Comparison

Price, market cap, valuation, profitability and leverage metrics of GUBRF and MEDTR side by side.

GUBRFMEDTR
StockFund

If You Had Invested TRY 10,000

Metric Comparison

GUBRF vs MEDTR Comparison
MetricGUBRFMEDTRSector median
Last price (TL)268.7517.4612.18
Daily change−1.83%−2.40%−2.84%
Market capTRY 89.8BTRY 2.1BTRY 3.7B
P/E10.21170.1715.84
P/B2.120.590.86
Dividend yield1.12%0.66%0.91%
Return on equity22.15%0.34%0.48%
Free float19.74%20.21%35.05%
Ratios are calculated from the latest published financial statements.

Popular Comparisons

Related Pages

About the GUBRF vs MEDTR Comparison

Price, market cap, valuation multiples, profitability and leverage of GUBRF (Gübre Fabrik.) and MEDTR (Meditera Tibbi Malzeme) side by side as of Nov 20, 2026, 18:19. Of the 15 metrics compared, GUBRF leads in 8 and MEDTR leads in 7.

Highlights: Daily change: GUBRF leads (−1.83% vs −2.40%). Market cap: GUBRF leads (TRY 89.8B vs TRY 2.1B). P/E: GUBRF leads (10.21 vs 170.17). P/B: MEDTR leads (0.59 vs 2.12). EV/EBITDA: MEDTR leads (4.77 vs 7.03). EV/Sales: MEDTR leads (0.70 vs 1.45). Dividend yield: GUBRF leads (1.12% vs 0.66%). Gross margin: MEDTR leads (35.58% vs 24.06%).

Frequently Asked Questions

By P/E, GUBRF is cheaper (10.21 vs 170.17); by P/B, MEDTR trades at the lower multiple (2.12 vs 0.59).

Annual net margin is 14.01% for GUBRF and 0.49% for MEDTR; return on equity is 22.15% for GUBRF and 0.34% for MEDTR.

The leverage ratio is 43.29 for GUBRF and 16.46 for MEDTR; net debt/EBITDA is −0.45 for GUBRF and — for MEDTR. Lower values mean less leverage.

Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.